Hart, S., Goh, K. C., Novotny-Diermayr, V., Tan, Y. C., Madan, B., Amalini, C., . . . Wood, J. M. (2011). Pacritinib (SB1518), a JAK2/FLT3 inhibitor for the treatment of acute myeloid leukemia. Nature Publishing Group.
Chicago Style CitationHart, S., et al. Pacritinib (SB1518), a JAK2/FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia. Nature Publishing Group, 2011.
Cita MLAHart, S., et al. Pacritinib (SB1518), a JAK2/FLT3 Inhibitor for the Treatment of Acute Myeloid Leukemia. Nature Publishing Group, 2011.
Atenció: Aquestes cites poden no estar 100% correctes.